Defective expression of early activation genes in cartilage-hair hypoplasia (CHH) with severe combined immunodeficiency (SCID).
Cartilage-hair hypoplasia (CHH) is an autosomal recessive disease of unknown etiology characterized by metaphyseal dysostosis, unpigmented hair, and defective cellular immunity. We studied peripheral blood mononuclear cells (PBMC) of a boy with CHH and combined immunodeficiency in an attempt to characterize further the immune defect in this disease. Stimulation of his PBMC with mitogens was associated with severely depressed IL-2 and interferon-gamma (IFN-gamma) synthesis and IL-2 receptor alpha-chain (IL-2R alpha) expression and resulted in poor lymphocyte proliferation that was only modestly upregulated by the addition of recombinant IL-2 (rIL-2). The defective proliferation and lymphokine synthesis were not corrected by the addition of phorbol myristate acetate (PMA) and ionomycin, agents that bypass receptor-mediated signalling, indicative of a distal abnormality. Importantly, the levels of mRNA encoding c-myc, IL-2R alpha, IL-2 and IFN-gamma were markedly decreased in patient lymphocytes stimulated with PMA+ionomycin as compared to control lymphocytes. The defect in the expression of these early activation genes was selective in that induction by mitogens of mRNA encoding other early activation gene products such as c-fos and c-jun was not impaired. These results suggest that the underlying defect in this patient and perhaps others with CHH may be an abnormality in a component of intracellular signalling pathways or in a trans-acting factor which regulates the expression of a selected number of early activation genes.
Castigli
E
E
Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Irani
A M
AM
Geha
R S
RS
Chatila
T
T
D002648:Child; D016207:Cytokines / Q000235:genetics; D004392:Dwarfism / Q000235:genetics*; D004413:Dysostoses / Q000235:genetics*; D005786:Gene Expression Regulation; D016762:Genes, fos; D016259:Genes, myc; D006201:Hair Diseases / Q000235:genetics*; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D010859:Pigmentation Disorders / Q000235:genetics*; D016511:Severe Combined Immunodeficiency / Q000235:genetics*
D016207:Cytokines